Kent, Washington Approves a Second Opioid Treatment Program on West Hill

Kent will get a second opioid treatment program after the city's hearing examiner approved a conditional use permit for Therapeutic Health Services to expand an existing clinic on the West Hill, ending a review that turned on whether a medication clinic belongs inside a shopping center.

Hearing examiner Brian McGinn published the decision on Oct. 7, clearing THS to add an opioid treatment program, or OTP, inside Soundview Plaza at 24823 Pacific Highway S. The clinic already operates in the building and provides a range of health services; the expansion is 2,883 square feet of interior improvement work with no changes to the exterior, and the new space will be used for medication-assisted treatment, substance use disorder counseling, behavioral health services, case management and other supports.

An approval that turns on the building, not the medicine

McGinn found the proposed use would not be detrimental to other uses in the commercial manufacturing zone, largely because the site is already a fully developed commercial center and the project adds no square footage beyond the tenant's own walls. No commercial tenant or nearby business submitted comments opposing the proposal. The decision notes the design includes a waiting area for treatment, which the examiner said removes any reason for people to gather outside.

THS told the city it manages foot traffic with "color dosing," spreading appointment times across operating hours so that patients do not arrive at once, and it stations program liaisons at its facilities to prevent loitering and keep clients from wandering into nearby neighborhoods. The city also determined the proposal had little enough transportation impact that no new driveways, roadway work or other offsite improvements were required, and that the shopping center's existing parking is more than sufficient for THS and its neighbors.

Neighbors' concerns, and the examiner's answer

Some residents to the west of the site raised concerns about how clients might behave, according to the decision. McGinn wrote that services at the site will be delivered in a controlled environment under professional supervision inside the building, and that the use is not anticipated to generate noise, odor, vibration, glare, smoke or other offsite impacts beyond those typical of professional or office space. A green belt along the western border, with vegetation and a steep slope the examiner described as difficult to navigate on foot, provides a buffer between the clinic and the residential area.

The decision addresses the broader objection directly. "As a broad proposition, the Applicant is not responsible for the already existing problems caused by drugs and homelessness," McGinn wrote. "These are societal ills, not problems to be solved by one applicant." He added that while the program will bring patients traveling to the commercial center, "there is no specific evidence to support the prediction that those seeking treatment will cause problems for area residents."

Traffic will increase, the examiner conceded, but not to a level likely to be significant.

The gap the program is meant to fill

Kent has only one other opioid treatment facility, and the decision describes an unfulfilled need in the southern part of the city. THS told the city that some clients currently travel to Seattle for dosing, and McGinn treated that travel as the evidence of the gap. He concluded the facility would address an obvious need.

Opioid treatment programs occupy a uniquely restricted place in American medicine: methadone may only be dispensed through a federally certified OTP, which is also why they are among the most frequently contested medical uses at the local level. The land use permit is often the practical gate for whether a community gets one at all.

What the permit does and does not settle

The conditional use permit authorizes the OTP within the expanded tenant space consistent with the application. Any substantial expansion, intensification or material change to the approved use would require new review. Exterior modifications, including signage, lighting and fencing, each require separate city approval, meaning the public process around the site is not entirely closed.

What the decision does not do is guarantee the program opens on any particular timeline. The permit is the land use half of the process; THS still has to satisfy state and federal requirements to operate an opioid treatment program, a category that requires certification by the Substance Abuse and Mental Health Services Administration and registration with the Drug Enforcement Administration.

For people in the southern half of the city who are already on medication, the practical effect is a shorter trip and, in the agency's account, less reason to leave treatment altogether.